trimethoprim--sulfamethoxazole-drug-combination has been researched along with Scarlet-Fever* in 3 studies
3 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Scarlet-Fever
Article | Year |
---|---|
Scarlet fever caused by community-associated methicillin-resistant Staphylococcus aureus.
We describe a previously healthy 2.5-year-old boy with staphylococcal scarlet fever associated with acute suppurative otitis media due to community-associated methicillin-resistant Staphylococcus aureus. The patient was successfully treated by spontaneous drainage in combination with trimethoprim-sulfamethoxazole therapy. Topics: Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Multilocus Sequence Typing; Otitis Media, Suppurative; Scarlet Fever; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
We report a case of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) secondary to trimethoprim-sulfamethoxazole (TMP-Sx) therapy for presumed community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection. Although the association between SJS/TEN and the sulfonamide class of antibiotics is well established, the increasing prevalence of CA-MRSA has left practitioners with limited regimens to effectively treat skin and soft tissue infections (SSTIs) in the outpatient setting. In the case of SSTIs, alternative treatment of these infections should be considered, especially when the bacterial pathogen is unknown. Future investigations evaluating the efficacy of adjunctive antibiotics for purulent SSTIs and monitoring the incidence of SJS/TEN in the era of CA-MRSA are necessary to reduce unnecessary use of sulfonamide drugs. The potential development of SJS/TEN, a severe life-threatening illness, emphasizes the need for judicious use of TMP-Sx and close monitoring and follow-up for patients who were given TMP-Sx for SSTIs. Topics: Adolescent; Anti-Bacterial Agents; Cellulitis; Communicable Diseases, Emerging; Community-Acquired Infections; Diagnostic Errors; Humans; Immunoglobulins, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Recurrence; Scarlet Fever; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
[Recurrent scarlet fever].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Penicillins; Recurrence; Scarlet Fever; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |